GLP-1 receptor agonist (RA) medications are highly effective for managing weight and blood sugar, but they can also disrupt digestive healthleading to discomfort, irregularity, and microbial imbalance
In a recent study published in the eClinicalMedicine , a group of researchers evaluated the association between Glucagon-like peptide-1 receptor agonists (GLP-1 RA) use and the risk of suicide or suicide attempt, accounting for psychiatric history and obesity
Personalized treatment plan from a licensed provider Includes online consultation, medication, and shipping Transparent monthly pricing no hidden fees Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate
Prices and partnerships Access to the drugs has also expanded through cash-pay programs
Only one study compared GLP1-RAs [51]
Liraglutide (LEADER trial), semaglutide (SUSTAIN-6), and dulaglutide (REWIND trial) demonstrated significant reductions in major adverse cardiovascular events